Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Conditions

Mycoses 2Leukemia 2Invasive Fungal Infections 2Pulmonary Aspergillosis 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Neutropenia 1Neoplasms 1Leukemia, Myelomonocytic, Acute 1Invasive Pulmonary Aspergillosis 1Hematologic Neoplasms 1HIV Infections 1Colorectal Neoplasms 1Aspergillosis 1Anastomotic Leak 1

Interventions

pembrolizumab 180Gemcitabine 168Paclitaxel 150Carboplatin 134Bevacizumab 126Cisplatin 113Docetaxel 112Cyclophosphamide 109Exercise 97Nivolumab 93Fluorouracil 88Capecitabine 85Dexamethasone 81Irinotecan 74Radiotherapy 68Oxaliplatin 68Pemetrexed 66Standard of Care 64Leucovorin 63Cetuximab 59Sorafenib 53Erlotinib Hydrochloride 53Drug Therapy 53Blood Specimen Collection 51Doxorubicin 50atezolizumab 48trametinib 47Ipilimumab 47Albumin-Bound Paclitaxel 44130-nm albumin-bound paclitaxel 42

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Neoplasms × Amphotericin B × Clear all
NCT00002277 2005-06-24

A Comparison of Fluconazole and Amphotericin B in the Treatment of Fungal Infections

NIH AIDS Clinical Trials Information Service

Phase 3 Completed

Mycoses, Neoplasms, Neutropenia, HIV Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡